The EPS projection of ResMed Inc. (NYSE:RMD) for quarter ended 2016-09-30 is $0.67. A week before, the EPS forecast was $0.67 against target of $0.67, a month earlier. This estimate stood at $0.67 60 days earlier versus forecast of $0.67 90 days earlier, confirming a deviation of 0%.
ResMed Inc. (NYSE:RMD) reported that 18 days ago, the positive EPS revisions were 2 and negative revisions at 2.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 2, 1, 0 and 2, respectively.
The downgrade of EPS estimates for ResMed Inc. (NYSE:RMD) in the preceding 120, 60, 30 and 90 days were 1, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 3, the EPS estimate of ResMed Inc. (NYSE:RMD) was $0.67. This projection was computed after accounting 5 calls. As reported on 2016-04-26 the EPS was $0.68. The change was $-0.01, demonstrating a percentage deviation of -1.45%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for ResMed Inc. (NYSE:RMD) stands at $547.283 and the median estimate at $546.65. Almost 3 analysts announced their estimates.
The highest estimate is $550.2 while the lowest target is $545 showing standard deviation of 2.657%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. ResMed Inc. (NYSE:RMD) stated that the change in forecast was 6.392%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...